Dies ist eine HTML Version eines Anhanges der Informationsfreiheitsanfrage 'Vaccine talks'.





The Members were reminded to follow up on their commitment 
 
 enable the signature of APAs with vaccine providers/manufacturers. 
The Members discussed various aspects on the logistic, which can be relevant in a strategic 
discussion on the 
vaccines. 
The Members were informed that at the next meeting AstraZeneca would provide an update on 
Clinical trials, manufacturing and approval. 
The Commission provided a short update on the state of play regarding the Joint procurement 
for the supply of medical equipment for COVID-19 vaccination
, for which the evaluation of 
the tender evaluation was ongoing.  
 
The Commission anticipates the evaluation to be finalized by 
 (largely depending 
on the quality of offers and reactivity of companies), while the orders could be placed as of 
 ensuring that supplies are available in time for national deployment of COVID-19 
vaccines. 
 
The Commission also asked the MSs to inform if they launched or signed national procurement 
on syringes and needles in parallel, information that could be relevant for adjusting the offer to 
the needs of the Member States. Note post meeting: The update should be send to:  
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx@xx.xxxxxx.xx
 
O
 
  
The Committee informed that the Joint Procurement Steering Committee would meet 
 
 and update on the joint procurement of syringes and needles.